We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
MSCI
MSCI
$40.9B
| $3.74M | 0.03% |
8,384
+72
| +0.9% | +$28.3K |
|
377
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
| $3.68M | 0.03% |
70,558
+42,955
| +156% | +$2.24M |
|
378
iShares 3-7 Year Treasury Bond ETF
IEI
$17.8B
| $3.67M | 0.03% |
27,571
-1,145
| -4% | -$152K |
|
379
Biogen
BIIB
$30.7B
| $3.66M | 0.03% |
14,969
-7,974
| -35% | -$2.06M |
|
|
BRW
380
Saba Capital Income & Opportunities Fund
BRW
$339M
| $3.64M | 0.03% |
407,585
-1,335
| -0.3% | -$11.8K |
|
381
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
| $3.64M | 0.03% |
90,881
+1,244
| +1% | +$46.6K |
|
382
Teradyne
TER
$59.3B
| $3.64M | 0.03% |
30,333
+13,701
| +82% | +$1.4M |
|
383
New Oriental
EDU
$8.98B
| $3.62M | 0.03% |
19,502
-271
| -1% | -$45.6K |
|
384
iShare MSCI Eurozone ETF
EZU
$9.91B
| $3.6M | 0.03% |
81,700
-1,821
| -2% | -$75.2K |
|
|
XIFR
385
XPLR Infrastructure LP
XIFR
$1.08B
| $3.53M | 0.03% |
52,716
+17,372
| +49% | +$1.12M |
|
386
Global Payments
GPN
$22.8B
| $3.52M | 0.03% |
16,335
+328
| +2% | +$61.2K |
|
387
Starwood Property Trust
STWD
$6.09B
| $3.52M | 0.03% |
182,224
+5,587
| +3% | +$95.1K |
|
388
General Mills
GIS
$19.7B
| $3.5M | 0.03% |
59,518
-1,371
| -2% | -$82.9K |
|
389
Vanguard FTSE Pacific ETF
VPL
$8.43B
| $3.49M | 0.03% |
43,880
-816
| -2% | -$60K |
|
390
Trane Technologies
TT
$106B
| $3.45M | 0.03% |
23,756
+5,849
| +33% | +$808K |
|
391
Canadian Pacific Kansas City
CP
$80.5B
| $3.35M | 0.03% |
48,385
+13,130
| +37% | +$855K |
|
392
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.26B
| $3.35M | 0.03% |
123,412
+6,753
| +6% | +$181K |
|
393
PNC Financial Services
PNC
$101B
| $3.31M | 0.03% |
22,253
-1,023
| -4% | -$131K |
|
394
Snap-on
SNA
$21.5B
| $3.31M | 0.03% |
19,341
+457
| +2% | +$76.4K |
|
395
Altria Group
MO
$114B
| $3.29M | 0.02% |
80,129
+43,833
| +121% | +$1.76M |
|
396
iShares MSCI South Korea ETF
EWY
$24.1B
| $3.28M | 0.02% |
38,160
+37,114
| +3,548% | +$2.75M |
|
397
Sea Limited
SE
$69.5B
| $3.25M | 0.02% |
16,308
+7,532
| +86% | +$1.34M |
|
398
Ericsson
ERIC
$33.3B
| $3.24M | 0.02% |
271,561
+33,825
| +14% | +$396K |
|
399
Pool Corp
POOL
$7.5B
| $3.24M | 0.02% |
8,691
+2
| +0% | +$698 |
|
400
Copart
CPRT
$27.5B
| $3.23M | 0.02% |
101,500
+3,244
| +3% | +$94.5K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.